Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes
Highton PJ, Funnell MP, Gupta P, et al.
Diabetologia. Pub. online 28 Nov 2025.
Leggi
Breaking news
High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks
Cho SH, Kim S, Oh R, et al.
Diabetologia. Pub. online 26 Nov 2025.
Leggi
Assessing the independent and combined impact of obesity and gestational diabetes mellitus on adverse maternal outcomes: a systematic review and meta-analysis
Weir TL, Majumder M, Glastras SJ
Diabet Med. Pub. online 27 Nov 2025.
Leggi
Glucagon-like peptide-1 receptor agonists and chronic cough
Gallagher TJ, Razura DE, Li A, et al.
JAMA Otolaryngol Head Neck Surg. Pub. online 26 Nov 2025.
Leggi
The effectiveness and safety of a mobile application-based self-regulation intervention to support weight loss among adults living with obesity: a large-scale pragmatic randomised controlled trial
Doody P, Wren GM, Mounsey S, et al.
BMC Med. Pub. online 29 Nov 2025.
Leggi
Comparative effectiveness of SGLT2 sodium-glucose cotransporter-2 inhibitors and GLP-1 glucagon-like peptide-1 receptor agonists for incident dementia: a retrospective multicohort study
Anagnostakis F, Kokkorakis M, Nagarajan S, et al.
Diabetes Obes Metab. Pub. online 27 Nov 2025.
Leggi
High serum isthmin-1 as a biomarker for the progression of renal function decline in patients with type 2 diabetes mellitus
Wang C, Cheng Y, Xu M, et al.
BMC Endocr Disord. Pub. online 27 Nov 2025.
Leggi
WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults
1 dicembre 2025
Leggi
AIFA: Verso un modello fast-track per l’autorizzazione di studi clinici multinazionali nell’UE/SEE
28 novembre 2025
Leggi
Effect of semaglutide on insulin sensitivity and cardiometabolic risk factors in adolescents with obesity: the STEP TEENS study
Arslanian S, Gies I, Goldman B, et al.
Diabetes Care. Pub. online 26 Nov 2025.
Leggi